Are you facing challenges meeting the FSA’s requirements to legally sell cannabinoid extracts? ACI can help.
69% of applications on FSA’s public CBD list are linked to the ACI consortium, become a member and be part of this success.
The UK has the world’s most developed robust regulatory framework for legal cannabinoids. This market is estimated to be worth £690 million ($1 billion) in 2021, making it the second largest in the world after the US.
Representation – We represent our members at the highest level so their voice is heard and a favourable regulatory environment exists.
Data – Cost-effective access to toxicological data required to gain novel foods authorisation from FSA (UK) and EFSA (EU). We have ensured that all of our members gained the Novel Foods validation necessary to stay in the UK market.
Technical consultancy – Our team of industry experts offer bespoke consultancy solutions to support our members.
Medicinal cannabis support – Through our sister organisation The Centre for Medicinal Cannabis.
ACI offers
- Industry representation
- Access to necessary toxicological data to enter UK's £690 million market
- Toxicological data for EU market authorisation
- Access to industry expertise
- Exposure to mainstream retail
- Trading Standards partnership
- Networking opportunities
Who should join?
If you are already established or looking to enter the UK’s legal cannabinoid market ACI membership can benefit you.
ACI offers solutions for raw material suppliers, manufacturers, brands, retailers and others operating in this space.
Introduction to ACI
Get a membership quote
Membership requirements can vary depending on which services you require to enter the UK market.
Please provide some details about your business and one of our team will contact you to arrange a call with an ACI expert. This way we can give you an accurate quotation. See ACI membership key benefits.
What our members are saying
